icone plus
Contact Abonnez-vous aux actualités
Reason for request
Re-assessment of the target population of AFINITOR, in combination with exemestane, in the treatment of advanced breast cancer in postmenopausal women in line with article R-163-19 of the French Social Security Code.
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
tk4RSQsJ6ccyGYy0
Listen
